RESI San Francisco 2018 was the biggest Redefining Early Stage Investments event yet. In a highly competitive RESI Innovation Challenge we saw novel technologies represented from the therapeutics, medtech, diagnostics, and healthcare IT verticals - we know it was tough for RESI attendees to choose how to allocate their 5 RESI "investment" tokens! We wish all our finalists the best in bringing their products forward toward commercialization, but there could only be 3 top prize winners.
First Place: CorInnova
Boris Leschinsky, VP of Product Development, CorInnova | Dennis Ford, CEO, Life Science Nation | William Altman, CEO, CorInnova | Keith Svagerko, VP ,Business Development, CorInnova
Second Place: ImmunoBiochem Corporation
Dennis Ford, CEO, Life Science Nation | Anton Neschadim, CEO, ImmunoBiochem | Lucy Parkinson, Director of Investor Research, LSN
Third Place: Biorez
Dennis Ford, CEO, Life Science Nation | Kevin Rocco, CEO, Biorez | Lucy Parkinson, Director of Investor Research, LSN
Thank you to all who competed in the RESI JPM Innovation Challenge, and to all the RESI attendees who took part by investing their votes in their favorite competing companies.
Welcome to join our upcoming RESI on MaRS event on April 10th, register now.
I
n honor of the Grand Opening of JLABS @ NYC, Johnson & Johnson Innovation has launched a QuickFire Challenge to award up to four new game-changing early-stage innovation companies with the use of a bench, workstation and access to the JLABS @ NYC community for one year.
This competition will award the person or team(s) who submits the best idea, technology, or solution in the following areas:
